OBI Pharma (4174) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.176x

Based on the latest financial reports, OBI Pharma (4174) has a cash flow conversion efficiency ratio of -0.176x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$-479.25 Million ≈ $-15.10 Million USD) by net assets (NT$2.73 Billion ≈ $85.86 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See OBI Pharma balance sheet independence to measure how much of total assets are equity-financed.

OBI Pharma - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how OBI Pharma's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OBI Pharma earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.

OBI Pharma Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of OBI Pharma ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Dimerix Ltd AU:DXB	3.087x
Quoc Cuong Gia Lai JSC VN:QCG	0.004x
SHANGHAI FUDAN H YC-,10 F:FDY	N/A
Kluang Rubber Company Malaya KLSE:2453	-0.001x
Anderson Industrial Corp TW:1528	0.021x
Whanin Pharm KO:016580	0.006x
Sunflow Sustain TA:SNFL	0.059x
M.I.TECH Co.Ltd KQ:179290	0.047x

Annual Cash Flow Conversion Efficiency for OBI Pharma (2011–2025)

The table below shows the annual cash flow conversion efficiency of OBI Pharma from 2011 to 2025. For the full company profile with market capitalisation and key ratios, see how much is OBI Pharma worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$2.73 Billion ≈ $85.86 Million	NT$-2.02 Billion ≈ $-63.65 Million	-0.741x	-94.89%
2024-12-31	NT$4.82 Billion ≈ $151.87 Million	NT$-1.83 Billion ≈ $-57.77 Million	-0.380x	-13.99%
2023-12-31	NT$4.95 Billion ≈ $156.06 Million	NT$-1.65 Billion ≈ $-52.08 Million	-0.334x	-26.42%
2022-12-31	NT$6.14 Billion ≈ $193.32 Million	NT$-1.62 Billion ≈ $-51.03 Million	-0.264x	+4.01%
2021-12-31	NT$3.87 Billion ≈ $121.95 Million	NT$-1.06 Billion ≈ $-33.54 Million	-0.275x	+17.34%
2020-12-31	NT$4.84 Billion ≈ $152.42 Million	NT$-1.61 Billion ≈ $-50.71 Million	-0.333x	-65.38%
2019-12-31	NT$5.20 Billion ≈ $163.96 Million	NT$-1.05 Billion ≈ $-32.98 Million	-0.201x	-4.12%
2018-12-31	NT$4.47 Billion ≈ $140.94 Million	NT$-864.31 Million ≈ $-27.23 Million	-0.193x	+11.67%
2017-12-31	NT$5.06 Billion ≈ $159.43 Million	NT$-1.11 Billion ≈ $-34.87 Million	-0.219x	-60.41%
2016-12-31	NT$6.16 Billion ≈ $194.10 Million	NT$-840.10 Million ≈ $-26.47 Million	-0.136x	-163.20%
2015-12-31	NT$7.18 Billion ≈ $226.34 Million	NT$-372.20 Million ≈ $-11.73 Million	-0.052x	+83.89%
2014-12-31	NT$1.44 Billion ≈ $45.49 Million	NT$-464.22 Million ≈ $-14.63 Million	-0.322x	-495.51%
2013-12-31	NT$1.93 Billion ≈ $60.78 Million	NT$-104.16 Million ≈ $-3.28 Million	-0.054x	+61.92%
2012-12-31	NT$829.77 Million ≈ $26.14 Million	NT$-117.64 Million ≈ $-3.71 Million	-0.142x	+85.82%
2011-12-31	NT$508.44 Million ≈ $16.02 Million	NT$-508.22 Million ≈ $-16.01 Million	-1.000x	--

About OBI Pharma

TWO:4174 Taiwan Biotechnology

Market Cap

$104.05 Million

NT$3.30 Billion TWD

Market Cap Rank

#18987 Global

#1032 in Taiwan

Share Price

NT$25.10

Change (1 day)

+0.80%

52-Week Range

NT$23.25 - NT$50.50

All Time High

NT$743.00